Abstract:【Objective】 To determine the effect of butorphanol associated with dexmedetomidine for endoscopic retrograde cholangiopancreatography in the elderly. 【Methods】 Forty elderly patients scheduled to undergo endoscopic retrograde cholangiopancreatography were randomly assigned to two groups (observation and control group) with 20 each. All patients received intravenous 0.5μg/(kg·h) dexmedetomidine after 0.5μg/kg bolus within 15 minutes. Intravenous butorphanol 1 mg was added in observation group. MAP, HR, RR and SPO2 were observed before anesthesia (T0), after intravenous dexmedetomidine and butorphanol (T1), at putting endoscope into stomach (T2), duodenal intubation (T3), contrast medium infusion (T4), the end of surgery (T5). Rasmay sedation score was determined at T1~T5. Patient compliance and satisfaction, the adverse effect such as bradycardia, hypotension, hypoxia, arrhythmia, excessive sedation were also recorded. 【Results】 MAP at T3 in control group was higher (P <0.05). Rasmay sedation scores were obviously lower at T1~T5 in observation group (P <0.05). The observation group was superior to control group in patient compliance and satisfaction (P <0.05). 【Conclusion】 Butorphanol associated with dexmedetomidine for endoscopic retrograde cholangiopancreatography in the elderly can get stable haemodynamics, satisfactory analgesia and sedation and excellent patient compliance and satisfaction.